| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92004 |
|
5,800 |
5,545 |
$628K |
| 92014 |
|
6,458 |
6,237 |
$580K |
| 92015 |
|
15,041 |
14,461 |
$219K |
| 67028 |
|
4,052 |
2,876 |
$161K |
| 99214 |
|
2,288 |
1,922 |
$140K |
| 92134 |
|
4,323 |
3,637 |
$80K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,208 |
1,760 |
$65K |
| 99213 |
|
515 |
466 |
$32K |
| 92012 |
|
577 |
464 |
$27K |
| 99204 |
|
88 |
87 |
$13K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
14 |
14 |
$7K |
| 92250 |
|
114 |
112 |
$3K |
| 92060 |
|
27 |
27 |
$2K |
| 99203 |
|
12 |
12 |
$832.77 |
| 92133 |
|
12 |
12 |
$311.60 |
| 92020 |
|
15 |
13 |
$247.52 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
8,244 |
7,663 |
$4.60 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
435 |
385 |
$4.60 |
| G8785 |
Blood pressure reading not documented, reason not given |
12,270 |
11,514 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
12,381 |
11,448 |
$0.01 |
| 1036F |
|
8,816 |
8,190 |
$0.00 |
| G8756 |
No documentation of blood pressure measurement, reason not given |
452 |
399 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
3,227 |
3,126 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
918 |
858 |
$0.00 |
| 4177F |
|
124 |
99 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
127 |
111 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
32 |
27 |
$0.00 |
| 3285F |
|
26 |
24 |
$0.00 |
| 3284F |
|
41 |
37 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
12 |
12 |
$0.00 |
| 0517F |
|
116 |
106 |
$0.00 |
| 5010F |
|
171 |
152 |
$0.00 |
| 2022F |
|
840 |
733 |
$0.00 |
| 2024F |
|
786 |
692 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
119 |
98 |
$0.00 |
| 2026F |
|
454 |
406 |
$0.00 |
| 2027F |
|
12 |
12 |
$0.00 |